The Gliknik approach is based on an unshakeable core commitment to scientific rigor in discovering and in developing innovative biologics for individuals with autoimmune diseases and cancer. We believe in:

  • extensively testing a compound before we are committed to its further development,
  • using multiple outside investigators to replicate each other’s work, and
  • leveraging multiple preclinical models because no one model perfectly mimics the human condition.

We are willing to take on big challenges which we pursue with scientific vigilance. Our investors appreciate this careful approach and encourage us to follow this path of scientific pursuit.